I notice Bionomics has put on rather a spurt in the last few days on no news except a very up beat analyst's report. Bell Potter still doesn't have the latest research report on its Bell direct site (the 28 Feb 2017 report is still showing). Perhaps SPL should have a word in the ear of its favourite broker.
Further there are four different reports with recommendations on Bionomics (BNO) (a smaller concern capital wise than ours) and only one which seems to have an opinion on SPL.
Vivagel BV Projections, page-21
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
